首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway.
【24h】

Pharmacophore based discovery of potential antimalarial agent targeting haem detoxification pathway.

机译:基于药理学的潜在抗疟药靶向血红素排毒途径的发现。

获取原文
获取原文并翻译 | 示例
           

摘要

Pharmacophore hypotheses were generated from molecules having putative antimalarial activities targeting haem detoxification pathway of malarial parasite. A training set consisting of 33 compounds, whose activities were evaluated for haem polymerization inhibition and against chloroquine resistant (K1) strain of Plasmodium falciparum, was optimized to generate hypotheses. The hypothesis showing optimum correlation between actual and estimated activities was validated by Fischer's randomization test at 95% confidence level and used as a model to screen our in-house compound database. Nicotinic acid [trans-3-(4-ethoxy-3-methoxy-phenyl)-1-(4-hydroxy-phenyl)-allylidene]-hydrazide (ALH5) was obtained as a hit. The compound was synthesized and evaluated against chloroquine sensitive (MRC-02) and resistant (RKL9) strains of malarial parasite P. falciparum. The compound showed antimalarial activity in nanomolar range and was found comparable with chloroquine.
机译:药理学假设是由具有抗疟疾活性的分子产生的,该分子具有抗疟原虫血红素解毒途径的功能。优化了由33种化合物组成的训练集,对它们的活性进行了血红素聚合抑制和抗恶性疟原虫抗氯喹(K1)菌株的评估,以产生假设。 Fischer的随机检验在95%置信水平下验证了显示实际活动与估计活动之间最佳相关性的假设,并用作筛选内部化合物数据库的模型。获得烟酸[反式-3-(4-乙氧基-3-甲氧基-苯基)-1-(4-羟基-苯基)-亚芳基]酰肼(ALH5)。合成了该化合物,并针对疟原虫恶性疟原虫的氯喹敏感株(MRC-02)和耐药株(RKL9)进行了评估。该化合物在纳摩尔范围内显示出抗疟活性,并与氯喹相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号